If you’ve been researching Accutane (isotretinoin), you’ve probably come across two very different approaches: the traditional, standard-dose course and the newer microdose (low-dose) protocol. Both use the same medication and both can lead to lasting clearance — but they differ in dose, timeline, side effects, and who they’re best suited for. Here’s how they compare.

What is traditional (standard-dose) Accutane?

Traditional Accutane is the classic, higher-dose course most people picture. Dosing is calculated from your body weight and acne severity, with the goal of reaching a target cumulative dose over roughly 6 to 12 months. Because the dose is higher, results tend to come faster and the odds of long-term or permanent clearance after a single course are high. The trade-off is that side effects — very dry lips and skin, occasional muscle aches, and the early “purge” — are more pronounced, and blood-work monitoring is especially important.

Standard dosing is typically the stronger choice for moderate-to-severe, cystic, nodular, or scarring acne, or acne that hasn’t responded to topicals and antibiotics.

What is microdose (low-dose) Accutane?

Microdose Accutane uses a lower daily dose taken over a longer period — often 18 to 24 months or more. The idea is to reach a similar cumulative benefit while keeping side effects milder and more manageable. Patients on a microdose protocol generally report less dryness and fewer day-to-day side effects, with a gentler, more gradual improvement.

Microdosing is an increasingly popular option for people with persistent mild-to-moderate acne that hasn’t cleared with topicals, or for those who want strong long-term results without committing to a high-dose course. It’s a clinical trend backed by a growing body of studies suggesting comparable clearance with a better side-effect profile for the right patients.

The key differences at a glance

  • Dose: Standard uses a higher daily dose; microdose uses a lower daily dose.
  • Duration: Standard runs ~6–12 months; microdose runs ~18–24+ months.
  • Side effects: More noticeable on standard dosing; typically milder on microdose.
  • Speed of results: Faster on standard dosing; slower and more gradual on microdose.
  • Best for: Standard for severe, cystic, or scarring acne; microdose for persistent mild-to-moderate acne or anyone prioritizing fewer side effects.

Which one is right for you?

Dose should always be a collaborative decision between you and your provider. The right choice depends on your acne severity, how you’ve responded to past treatments, your preferred timeline, cost considerations, and your overall health. Both approaches require the same safety oversight — including iPLEDGE enrollment, regular check-ins, and lab monitoring — regardless of dose.

Whichever route fits, a dermatology provider will tailor your dose and monitor you throughout treatment to keep it safe and effective.

This article is for general education and is not medical advice. Accutane (isotretinoin) carries serious risks, including severe birth defects if taken during pregnancy, and must be used under the supervision of a licensed provider through the iPLEDGE program.